Urinary incontinence is the involuntary loss of urine. It is a common ailment that affects up to 50% of women within their lifetime, and has a detrimental effect on quality of life. There are many effective treatments, including conservative and medical management, available in the community before referral to secondary care. It is essential that GPs have a good understanding of the assessment, primary management and indications for onward referral of this common complaint that has a significant impact on quality of life.
CoyneKSSextonCCIrwinDE, et al.(2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: Results from the EPIC study. BJU International101(11): 1388–1395. DOI: 10.1111/j.1464-410X.2008.07601.x.
3.
Dumoling C, Cacciari LP and Hay-Smith EJC (2018) Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews 10: art. no.: CD005654.
4.
Gray TG, Vickers H and Jha S (2019) Suspension of vaginal mesh operations for incontinence: Causes and consequences. InnovAiT 12(6): 345–348. DOI: 10.1177/1755738019834050.
5.
HunskaarSLoseGSykesD, et al.(2004) The prevalence of urinary incontinence in women in four European countries. BJU International93(3): 324–330.
6.
International Urogynaecological Association (2019) Patient information leaflets. Available at: www.yourpelvicfloor.org/leaflets/ (accessed 14 June 2019).
7.
IrwinDEKoppZSAgatepB, et al.(2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU International108(7): 1132–1138. DOI: 10.1111/j.1464-410X.2010.09993.x.
8.
KwonBEKimGYSonYJ, et al.(2010) Quality of life of women with urinary incontinence: A systematic literature review. International Neurourology Journal14(3): 133–138. DOI: 10.5213/inj.2010.14.3.133.
MinassianVAYanXLichtenfeldMJ, et al.(2012) The iceberg of health care utilization in women with urinary incontinence. International Urogynecology Journal23(8): 1087–1093. DOI: 10.1007/s00192-012-1743-x.
12.
NICE (2013) Technology appraisal guidance TA290: Mirabegron for treating symptoms of overactive bladder. Available at: www.nice.org.uk/Guidance/TA290 (accessed 14 June 2019).
13.
NICE (2019a) Urinary incontinence and pelvic organ prolapse in women: Management. Available at: www.nice.org.uk/guidance/ng123 (accessed 14 June 2019).
ReismsmaRHagenSKirschner-HermannsR, et al.(2017) Can incontinence be cured? A systematic review of cure rates. BMC Medicine15: 63. DOI: 10.1186/s12916-017-0828-2.
16.
RichardsonKFoxCMaidmentI, et al.(2018) Anticholinergic drugs and risk of dementia: Case-control study. BMJ361: k1315.
17.
SinclairAJRamseyIN (2011) The psychosocial impact of urinary incontinence in women. The Obstetrician and Gynaecologist13: 143–148. DOI: 10.1576?toag.13.3.143.27665.
18.
WallaceSARoeBPalmerM (2004) Bladder training for urinary incontinence in adults. Cochrane Database of Systematic Reviews1. art. no.: CD001308. DOI: 10.1002/14651858.CD001308.pub2.
